Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
06/2012
06/21/2012US20120156133 Non-radioactive phospholipid compounds, compositions, and methods of use
06/21/2012US20120156132 Targeting agent to newly formed blood vessels
06/21/2012US20120156131 Diagnosis and treatment of tumors
06/21/2012US20120156130 Use of her3 binding agents in prostate treatment
06/21/2012US20120156129 Novel antibodies
06/21/2012US20120156128 Controllable release composition and method for preparing same
06/21/2012US20120152262 Apparatus and method for moving and activating an active agent
06/21/2012CA2821024A1 Entrapment of radionuclides in nanoparticle compositions
06/21/2012CA2814953A1 Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
06/20/2012EP2464389A2 Oncology therapies employing radioactive seeds
06/20/2012EP1546203B1 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
06/20/2012EP1311267B1 A retroviral immunotherapy
06/20/2012CN101128219B Improved N4 chelating agent conjugate
06/19/2012US8202838 Methods for treatment of headaches by administration of oxytocin
06/19/2012US8202509 Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
06/19/2012US8202508 Pharmaceutical composition of nanoparticles for protein drug delivery
06/19/2012US8202507 Assay for vitamin B12 absorption and method of making labeled vitamin B12
06/19/2012CA2478012C Internalizing anti-cd74 antibodies and methods of use
06/14/2012WO2012078534A1 Psma-targeted dendrimers
06/14/2012WO2012076697A1 Radiotracer compositions
06/14/2012US20120149877 Tumor-specific recognition molecules
06/14/2012US20120149085 Fusion proteins containing recombinant cytotoxic rnases
06/14/2012US20120148492 Bisphosphonic acid derivative and compound thereof labeled with radioactive metal nuclide
06/14/2012US20120148491 Method of overcoming therapeutic limitations of nonuniform distribution of radiopharmaceuticals and chemotherapy drugs
06/14/2012US20120148490 Anti-ngf compositions and use thereof
06/14/2012US20120148489 Targeting Kidney Mesangium With Nanoparticles of Defined Diameter
06/14/2012US20120148488 Targeting Kidney Mesangium With Nanoparticles of Defined Diameter
06/14/2012CA2820671A1 Tnf-.alpha. binding proteins
06/14/2012CA2820387A1 Radiotracer compositions
06/14/2012CA2819850A1 Psma-targeted dendrimers
06/13/2012EP2463263A1 Isotope labeled 2-arylpropionic acid compounds and process for production of same, and molecular probe for positron emission tomography and method for imaging of cyclooxygenase and the like using same
06/13/2012EP2461835A1 Compositions containing jarid1b inhibitors and methods for treating cancer
06/13/2012EP2175888B1 Radiopharmaceutical compositions comprising polysaccharides grafted by polyamines
06/13/2012EP1490110B1 Anti-alpha v beta 6 antibodies
06/13/2012EP1297017B1 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
06/13/2012CN102488910A Application of radioisotope-marked sunshine anthrone compound in preparing anti-tumor medicine
06/13/2012CN102488909A Application of therapeutic isotope labeled Evans blue and its derivatives in preparing tumor targeted radiotherapy medicaments
06/12/2012US8198240 Methods for treatment of headaches by administration of oxytocin
06/12/2012US8198232 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
06/12/2012US8197793 Methods of radiofluorination of biologically active vectors
06/07/2012WO2012075361A2 In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
06/07/2012WO2012075241A2 Protease degradable polypeptides and uses thereof
06/07/2012WO2012072819A1 Agents for the molecular imaging of serine-protease in human pathologies
06/07/2012WO2012072736A2 Radioconjugation method
06/07/2012WO2012072728A1 Apoptosis pet imaging agents
06/07/2012US20120144506 Double-fusion human embryonic stem cells, method of making double-fusion human embryonic stem cells, triple-fusion human embryonic stem cells, method of making triple-fusion human embryonic stem cells, and methods of monitoring double-fusion human embryonic stem cells and triple-fusion human embryonic stem cells
06/07/2012US20120141377 Compositions and methods for treating cancer
06/07/2012US20120141376 Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics
06/07/2012US20120141375 Anti-Mucin Antibodies for Early Detection and Treatment of Pancreatic Cancer
06/07/2012US20120141374 Methods and compositions for targeting hepsin
06/07/2012US20120141373 Antibodies and Methods of Use Thereof
06/07/2012US20120141372 RS7 Antibodies
06/07/2012US20120141371 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
06/07/2012CA2819483A1 Apoptosis pet imaging agents
06/07/2012CA2819347A1 Radioconjugation method
06/07/2012CA2814962A1 In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
06/06/2012EP2460542A1 Pancreatic endocrine cell indicator and utilization of same
06/06/2012EP2460013A1 Folate-targeted diagnostics and treatment
06/06/2012EP2459236A2 Active ingredient and method for testing an active ingredient
06/06/2012EP2061814B1 Antibodies and immunoconjugates and uses therefor
06/06/2012CN101830937B Visualized double-reaction tube fluorine-18 multifunctional automated synthesis module
06/05/2012US8193360 Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging
06/05/2012US8192739 Fusion proteins containing recombinant cytotoxic RNAses
06/05/2012US8192718 Pharmaceutical composition of nanoparticles
06/05/2012US8192717 Composition for diagnosing amyloid-related diseases
06/05/2012CA2520653C Microwave method for preparing radiolabelled gallium complexes
06/05/2012CA2520176C Method of obtaining gallium-68 and use thereof and device for carrying out said method
06/05/2012CA2249352C Immunoliposomes that optimize internalization into target cells
05/2012
05/31/2012WO2012069535A1 Radioiodination method
05/31/2012WO2012069410A1 177lutetium-labeled bombesin analogs for radiotherapy
05/31/2012WO2012037648A8 Process for chelating copper ions using cb-te2a bifunctional chelate
05/31/2012WO2012024604A3 High-valent palladium fluoride complexes and uses thereof
05/31/2012US20120136024 3-Substituted-2-(arlyalkyl)-1-azabicycloalkanes and Methods of Use Thereof
05/31/2012US20120134923 Radioiodination method
05/31/2012US20120134922 Peptides whose uptake in cells is controllable
05/31/2012US20120134921 Solid compositions comprising 5-aminolevulinic acid
05/31/2012US20120134920 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules
05/31/2012US20120134919 Ion substituted calcium phosphate particles
05/31/2012US20120134918 Gum arabic coated 198gold radioactive nanoparticles for cancer therapy
05/31/2012US20120134917 Dermatological composition
05/31/2012CA2818694A1 177lutetium-labeled bombesin analogs for radiotherapy
05/30/2012EP2457914A1 Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
05/30/2012EP2457588A1 Microsphere comprising a lanthanide metal complex
05/30/2012EP2456472A1 Methods for generating radioimmunoconjugates
05/30/2012EP2456467A1 -polylysine conjugates and use thereof
05/30/2012EP2219683B1 Targeted radiotherapy
05/30/2012CN101838345B Fluorine-18-labelled galactosylated chitosan compound and preparation method thereof
05/30/2012CN101687803B Metal chelates having a perfluorinated peg group, method for the production thereof, and use thereof
05/30/2012CN101597323B Radioactive isotope labeling polypeptide for tumor imaging
05/30/2012CN101007850B Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen
05/29/2012US8188296 Gentisic acid for stabilising 123-I radiopharmaceuticals
05/29/2012US8188239 Multivalent carriers of bi-specific antibodies
05/29/2012US8187620 Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
05/29/2012US8187571 Pharmaceutical composition of nanoparticles
05/29/2012US8187570 Nanoparticles for protein drug delivery
05/29/2012CA2648099C System for targeted delivery of therapeutic agents
05/29/2012CA2395053C Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
05/24/2012WO2012068072A1 Use of cyanine dyes for the detection of tau for diagnosis of early-stage tauopathies
05/24/2012WO2012066498A1 Brachytherapy seed, methodology and calculating dose of brachytherapy and method of treatment
05/24/2012WO2012016050A3 Chemoradiotherapy for kras-mutant colorectal cancer
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 243